Aurinia Pharmaceuticals, Inc. (AUPH)
15.90
+0.43
(+2.78%)
USD |
NASDAQ |
Dec 11, 16:00
15.90
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Market Cap: 2.096B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 7.280B |
| Oncolytics Biotech, Inc. | 107.28M |
| Edesa Biotech, Inc. | 12.44M |
| Lexaria Bioscience Corp. | 27.56M |
| Xenon Pharmaceuticals, Inc. | 3.370B |
Market Cap Related Metrics
| PE Ratio | 28.34 |
| PS Ratio | 8.440 |
| Price to Book Value | 5.731 |
| Price to Free Cash Flow | 18.64 |
| Price | 15.90 |
| Earnings Yield | 3.53% |
| Operating PE Ratio | 23.10 |
| Normalized PE Ratio | 24.77 |